Home > M&A deals 2017 > ANI Pharmaceuticals, Inc. acquires Holmdel Pharmaceuticals LP - InnoPran XL
Divestiture · Life Science · February 2017

ANI Pharmaceuticals, Inc. acquires Holmdel Pharmaceuticals LP - InnoPran XL

On February 24, 2017, ANI Pharmaceuticals, Inc. acquired Holmdel Pharmaceuticals LP - InnoPran XL, a life science company in New Jersey, United States, from Holmdel Pharmaceuticals LP.

Deal at a glance

AnnouncedFebruary 24, 2017 TypeDivestiture TargetHolmdel Pharmaceuticals LP - InnoPran XL Buyer ANI Pharmaceuticals, Inc. Seller Holmdel Pharmaceuticals LP SectorLife Science LocationNew Jersey, United States ValueNot disclosed

Target company

Holmdel Pharmaceuticals LP - InnoPran XL
New Jersey, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

Company · 7 deals on record
  • 5th transaction in life science
  • 6th transaction in United States
7deals, all time
6in this sector
2018latest

Seller

Company · 1 deal on record
1investments
1in this sector
1exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Holmdel Pharmaceuticals LP - InnoPran XL?ANI Pharmaceuticals, Inc. acquired Holmdel Pharmaceuticals LP - InnoPran XL on February 24, 2017.

Who sold Holmdel Pharmaceuticals LP - InnoPran XL?Holmdel Pharmaceuticals LP was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2017.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).